JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nanji, A. A.
Right arrow Articles by Dannenberg, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nanji, A. A.
Right arrow Articles by Dannenberg, A. J.

Vol. 299, Issue 2, 638-644, November 2001

Dietary Saturated Fatty Acids Reverse Inflammatory and Fibrotic Changes in Rat Liver Despite Continued Ethanol Administration

Amin A. Nanji, Kalle Jokelainen, George L. Tipoe, Amir Rahemtulla and Andrew J. Dannenberg

Department of Pathology and Center for the Study of Liver Diseases, The University of Hong Kong, Hong Kong, China (A.A.N.); Research Unit of Alcohol Diseases, Helsinki University Central Hospital, Helsinki, Finland (K.J.); Department of Anatomy, The University of Hong Kong, Hong Kong, China (G.L.T.); Department of Pathology, Harvard Medical School, Boston, Massachusetts (A.R.); and Department of Medicine, Weill Medical College of Cornell University and Anne Fisher Nutrition Center at Strang Cancer Prevention Center, New York, New York (A.J.D.)

We investigated the potential of dietary saturated fatty acids to reverse alcoholic liver injury despite continued administration of alcohol. Five groups (six rats/group) of male Wistar rats were studied. Rats in groups 1 and 2 were fed a fish oil-ethanol diet for 8 and 6 weeks, respectively. Rats in groups 3 and 4 were fed fish oil and ethanol for 6 weeks before being switched to isocaloric diets containing ethanol with palm oil (group 3) or medium-chain triglycerides (MCTs, group 4) for 2 weeks. Rats in group 5 were fed fish oil and dextrose for 8 weeks. Liver samples were analyzed for histopathology, lipid peroxidation, nuclear factor-kappa B (NF-kappa B) activation, and mRNAs for cyclooxygenase-2 (Cox-2) and tumor necrosis factor-alpha (TNF-alpha ). Endotoxin in plasma was determined. The most severe inflammation and fibrosis were detected in groups 1 and 2, as were the highest levels of endotoxin, lipid peroxidation, activation of NF-kappa B, and mRNAs for Cox-2 and TNF-alpha . After the rats were switched to palm oil or MCT, there was marked histological improvement with decreased levels of endotoxin and lipid peroxidation, absence of NF-kappa B activation, and reduced expression of TNF-alpha and Cox-2. A diet enriched in saturated fatty acids effectively reverses alcohol-induced necrosis, inflammation, and fibrosis despite continued alcohol consumption. The therapeutic effects of saturated fatty acids may be explained, at least in part, by reduced endotoxemia and lipid peroxidation, which in turn result in decreased activation of NF-kappa B and reduced levels of TNF-alpha and Cox-2.

0022-3565/01/2992-0638$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Nutr.Home page
M. You, Q. Cao, X. Liang, J. M. Ajmo, and G. C. Ness
Mammalian Sirtuin 1 Is Involved in the Protective Action of Dietary Saturated Fat against Alcoholic Fatty Liver in Mice
J. Nutr., March 1, 2008; 138(3): 497 - 501.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. N. Baumgardner, K. Shankar, L. Hennings, T. M. Badger, and M. J. J. Ronis
A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet
Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G27 - G38.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
G. S. Lee, J. S. Yan, R. K. Ng, S. Kakar, and J. J. Maher
Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury
J. Lipid Res., August 1, 2007; 48(8): 1885 - 1896.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
A. Gonzalez-Periz, A. Planaguma, K. Gronert, R. Miquel, M. Lopez-Parra, E. Titos, R. Horrillo, N. Ferre, R. Deulofeu, V. Arroyo, et al.
Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA
FASEB J, December 1, 2006; 20(14): 2537 - 2539.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
E. Cabre, J. M Hernandez-Perez, L. Fluvia, C. Pastor, A. Corominas, and M. A Gassull
Absorption and transport of dietary long-chain fatty acids in cirrhosis: a stable-isotope-tracing study
Am. J. Clinical Nutrition, March 1, 2005; 81(3): 692 - 701.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
M. J. J. Ronis, R. Hakkak, S. Korourian, E. Albano, S. Yoon, M. Ingelman-Sundberg, K. O. Lindros, and T. M. Badger
Alcoholic Liver Disease in Rats Fed Ethanol as Part of Oral or Intragastric Low-Carbohydrate Liquid Diets
Experimental Biology and Medicine, April 1, 2004; 229(4): 351 - 360.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. J. J. Ronis, S. Korourian, M. Zipperman, R. Hakkak, and T. M. Badger
Dietary Saturated Fat Reduces Alcoholic Hepatotoxicity in Rats by Altering Fatty Acid Metabolism and Membrane Composition
J. Nutr., April 1, 2004; 134(4): 904 - 912.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.